Dr Matthew KrebsMB ChB MRCP PhD

Clinical Snr Lecturer in Exp Cancer Med

View graph of relations

Overview

Early phase clinical trials (e.g. first-in-human drugs or novel combinations of targeted/immuno-oncology therapies) with a focus in drug development for lung cancer

Precision medicine lead in Experimental Cancer Medicine Team, The Christie NHS Foundation Trust.

Translational circulating biomarker research

Personalised medicine with hypothesis-driven early phase clinical trials in biomarker-enriched populations 

Qualifications

PhD in Experimental Pharmacology and Circulating Biomarkers, University of Manchester 2011

Member of Royal College of Physicians (London), UK, 2005

Bachelor of Medicine and Bachelor of Surgery (MB ChB), University of Leicester, 2001

Biology, Medicine and Health (BMH) Domains

Related information